Symptom scores,serotonin and 5-hydroxyindole acetic acid levels in cancer patients with and without bowel obstruction

Abstract

Get full access to this article

View all access options for this article.

References

Baines M , Oliver DJ , Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985; 2: 990-993.

Bulbring E , Crema A. The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol 1959; 146: 18-28.

Matia I , Balaz P , Jackanin S , Rybarova E , Kron I , Pomfry M et al. Serotonin levels in the small bowel mucosa as a marker of ischaemic injury during small bowel preservation. Ann Transplant 2004; 9: 48-51.

Cubeddu LX. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients. Oncology 1996; 53: 18-25.

Prasad CN , Roy SK , Deenath PK , Sanyal AK. Importance of plasma serotonin in intestinal obstruction. Indian J Pharmacol 1977; 9: 11-16.

Hutchinson SMW , Beattie G , Shearing CH. Increased serotonin excretion in patients with ovarian carcinoma and intestinal obstruction. Palliat Med 1995; 9: 67-68.

Carling RS , Degg TJ , Allen KR , Bax ND , Barth JH. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002; 39: 577-582.

Lee MS , Cheng FC , Yeh HZ , Liou TY , Lui JH. Determination of plasma serotonin and 5-hydroxyindo-leacetic acid in healthy subjects and cancer patients. Clin Chem 2000; 46: 422-423.

Cubeddu LX , Hoffman IS. Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics. J Clin Pharmacol 1993; 33: 691-697.